SaaS Metrics
Adherence Barriers & Enablers
Medication Adherence
AI Synthesis & Market Narrative
High out-of-pocket costs directly impede medication adherence, particularly for GLP-1s, while continuous monitoring devices introduce data consent challenges. Conversely, partnerships for prescription delivery and multicomponent quality improvement strategies aim to enhance adherence and access.
Correlated Linguistic Patterns
["prescription fulfillment and delivery"
"cloud-connected CPAP device"
"meaningful control over his own data"
"out-of-pocket costs matter"
"multicomponent quality improvement strategy"
"Taking Care of Your Heart Every Day
Starting From Your Wrist"]
Driving Media Context
Novel Takes Veterinary Care Beyond the Clinic Through Partnership with Airvet
The partnership will enable Ontario-wide prescription fulfillment and delivery for Airvet members BURLINGTON, Ontario — Novel, the Ontario-based companion an...
When consent fails: Limits to consent in the era of continuous monitoring
By Yuvraj Walia A patient with sleep apnea receives a cloud-connected CPAP device. He’s told it will monitor his nightly use, he agrees, and life continues. ...
People are less likely to take their GLP-1s when they cost more
“The key takeaway from our study is that out-of-pocket costs matter.”
What is stage 4 of Addison’s disease?
Understanding Stage 4 of Addison’s Disease: A Critical Overview Stage 4 of Addison’s disease, often referred to as Addisonian crisis, is not a staged progres...
[World Heart Day] Taking Care of Your Heart Every Day, Starting From Your Wrist
No matter who you are or what you do, we all have one constant companion we rely on every single day: our heart. Unseen but always at work, it beats around 1...
Assessing a multicomponent quality improvement strategy for chronic care of cardiovascular diseases in India: The C-QIP randomized feasibility trial
Kavita Singh and colleagues evaluated a multicomponent quality improvement strategy for chronic cardiovascular disease care in India and found it was feasibl...
How Concurrence governs clinical AI at a trillion-token scale with Unity Gateway
Healthcare AI has little margin for error. AI agents helping coordinate patient care...
Overlooked Determinants of GLP-1 Usage
What else is going on with GLP-1 adherence besides cost and side effects?
HFSA's 2026 Annual Scientific Meeting to Feature Late-Breaking Trials That Could Reshape Heart Failure Treatment
October 9-12, 2026 | Phoenix, Arizona -- New data spans pharmacotherapy, imaging and diagnostics, and device therapy for patients with cardiomyopathy WASHING...
Modifiable determinants of adherence to tyrosine kinase inhibitors in classical myeloproliferative neoplasms: A mixed-methods systematic review protocol
Introduction Non-receptor Tyrosine kinase inhibitors (TKIs), such as ABL1 and JAK inhibitors, are central to the management of classical myeloproliferative n...